1	Abstract	abstract	JJ	JJ	rep=no|t=yes|r=no|m=yes|c=no	3	NMOD
2	Breast	breast	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	3	NMOD
3	cancer	cancer	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	4	SBJ
4	exhibits	exhibit	VBZ	VBZ	rep=no|t=no|r=yes|m=yes|c=no	0	root
5	familial	familial	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	6	NMOD
6	aggregation	aggregation	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	4	OBJ
7	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	4	P
8	consistent	consistent	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	4	ADV
9	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	8	AMOD
10	variation	variation	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	9	PMOD
11	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	10	LOC
12	genetic	genetic	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
13	susceptibility	susceptibility	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	11	PMOD
14	to	to	TO	TO	rep=no|t=no|r=yes|m=yes|c=no	10	NMOD
15	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	16	NMOD
16	disease	disease	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	14	PMOD
17	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	4	P

1	Known	know	VBN	VBN	rep=no|t=no|r=no|m=yes|c=no	0	root
2	susceptibility	susceptibility	NN	NN	rep=no|t=no|r=no|m=yes|c=no	3	NMOD
3	genes	gene	NNS	NNS	rep=no|t=no|r=no|m=yes|c=no	1	OBJ
4	account	account	VBP	VBP	rep=no|t=no|r=no|m=yes|c=no	1	OPRD
5	for	for	IN	IN	rep=no|t=no|r=no|m=yes|c=no	4	ADV
6	less	less	JJR	JJR	rep=no|t=no|r=no|m=yes|c=no	8	DEP
7	than	than	IN	IN	rep=no|t=no|r=no|m=yes|c=no	8	DEP
8	25_%	25/100	Zp	Zp	rep=no|t=no|r=no|m=yes|c=no	5	PMOD
9	of	of	IN	IN	rep=no|t=no|r=no|m=yes|c=no	8	NMOD
10	the	the	DT	DT	rep=no|t=no|r=no|m=yes|c=no	12	NMOD
11	familial	familial	JJ	JJ	rep=no|t=no|r=no|m=yes|c=no	12	NMOD
12	risk	risk	NN	NN	rep=no|t=no|r=no|m=yes|c=no	9	PMOD
13	of	of	IN	IN	rep=no|t=no|r=no|m=yes|c=no	12	NMOD
14	breast	breast	NN	NN	rep=no|t=no|r=no|m=yes|c=no	15	NMOD
15	cancer	cancer	NN	NN	rep=no|t=no|r=no|m=yes|c=no	13	PMOD
16	,	,	Fc	Fc	rep=no|t=no|r=no|m=yes|c=no	1	P
17	and	and	CC	CC	rep=no|t=no|r=no|m=yes|c=no	1	COORD
18	the	the	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	21	NMOD
19	residual	residual	JJ	JJ	rep=no|t=yes|r=no|m=yes|c=no	21	NMOD
20	genetic	genetic	JJ	JJ	rep=no|t=yes|r=no|m=yes|c=no	21	NMOD
21	variance	variance	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	22	SBJ
22	is	be	VBZ	VBZ	rep=no|t=no|r=yes|m=yes|c=no	17	CONJ
23	likely	likely	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	22	PRD
24	to	to	TO	TO	rep=no|t=no|r=yes|m=yes|c=no	23	AMOD
25	be	be	VB	VB	rep=no|t=no|r=yes|m=yes|c=no	24	IM
26	due	due	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	25	PRD
27	to	to	TO	TO	rep=no|t=no|r=yes|m=yes|c=no	26	AMOD
28	variants	variant	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	27	PMOD
29	conferring	confer	VBG	VBG	rep=no|t=no|r=yes|m=yes|c=no	28	APPO
30	more	more	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	31	AMOD
31	moderate	moderate	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	32	NMOD
32	risks	risk	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	29	OBJ
33	.	.	Fp	Fp	rep=no|t=no|r=no|m=yes|c=no	1	P

1	To	to	TO	TO	rep=no|t=no|r=no|m=yes|c=no	8	PRP
2	identify	identify	VB	VB	rep=no|t=no|r=no|m=yes|c=no	1	IM
3	further	further	JJ	JJ	rep=no|t=no|r=no|m=yes|c=no	4	NMOD
4	susceptibility	susceptibility	NN	NN	rep=no|t=no|r=no|m=yes|c=no	2	OBJ
5	alleles	allele	NNS	NNS	rep=no|t=no|r=no|m=yes|c=no	4	APPO
6	,	,	Fc	Fc	rep=no|t=no|r=no|m=yes|c=no	8	P
7	we	we	PRP	PRP	rep=no|t=yes|r=no|m=yes|c=no	8	SBJ
8	conducted	conduct	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
9	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
10	two-stage	two-stage	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
11	genome-wide	genome_wide	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	12	NMOD
12	association	association	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
13	study	study	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	8	OBJ
14	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	13	LOC
15	4,398	[??:??/??/4398:??.??:??]	W	W	rep=no|t=no|r=yes|m=yes|c=no	18	NMOD
16	breast	breast	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	17	NMOD
17	cancer	cancer	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	18	NMOD
18	cases	case	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	14	PMOD
19	and	and	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	13	COORD
20	4,316	4316	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	21	NMOD
21	controls	control	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	19	CONJ
22	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	21	P
23	followed	follow	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	21	APPO
24	by	by	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	23	LGS
25	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	27	NMOD
26	third	3	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	27	NMOD
27	stage	stage	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	24	PMOD
28	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	37	TMP
29	which	which	WDT	WDT	rep=no|t=no|r=yes|m=yes|c=no	28	PMOD
30	30	30	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	33	NMOD
31	single	single	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	33	NMOD
32	nucleotide	nucleotide	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	33	NMOD
33	polymorphisms	polymorphism	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	37	SBJ
34	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	35	P
35	SNPs	snps	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	33	APPO
36	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	35	P
37	were	be	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	27	NMOD
38	tested	test	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	37	VC
39	for	for	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	38	PRP
40	confirmation	confirmation	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	39	PMOD
41	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	40	LOC
42	21,860	21860	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	43	NMOD
43	cases	case	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	41	PMOD
44	and	and	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	40	COORD
45	22,578	22578	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	46	NMOD
46	controls	control	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	44	CONJ
47	from	from	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	46	NMOD
48	S22	S22	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	49	NMOD
49	studies	study	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	47	PMOD
50	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	8	P

1	We	we	PRP	PRP	rep=no|t=yes|r=no|m=yes|c=no	2	SBJ
2	used	use	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
3	227,876	227876	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	4	NMOD
4	SNPs	snps	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	2	OBJ
5	that	that	WDT	WDT	rep=no|t=no|r=yes|m=yes|c=no	6	SBJ
6	were	be	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	4	NMOD
7	estimated	estimate	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	6	VC
8	to	to	TO	TO	rep=no|t=no|r=yes|m=yes|c=no	7	OPRD
9	correlate	correlate	VB	VB	rep=no|t=no|r=yes|m=yes|c=no	8	IM
10	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	9	ADV
11	77_%	77/100	Zp	Zp	rep=no|t=no|r=yes|m=yes|c=no	10	PMOD
12	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	11	NMOD
13	known	know	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	15	NMOD
14	common	common	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	15	NMOD
15	SNPs	snps	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	12	PMOD
16	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	15	LOC
17	Europeans	europeans	NP00G00	NP	rep=no|t=no|r=yes|m=yes|c=no	16	PMOD
18	at	at	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	9	ADV
19	r2	r2	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	21	NMOD
20	>	>	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	21	NMOD
21	0.5	0.5	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	18	PMOD
22	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	2	P

1	SNPs	snps	NP00O00	NP	rep=no|t=yes|r=no|m=yes|c=no	7	SBJ
2	in	in	IN	IN	rep=no|t=yes|r=no|m=yes|c=no	1	NMOD
3	five	5	Z	Z	rep=no|t=yes|r=no|m=yes|c=no	4	NMOD
4	novel	novel	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	2	PMOD
5	independent	independent	JJ	JJ	rep=no|t=yes|r=no|m=yes|c=no	6	NMOD
6	loci	locus	NNS	NNS	rep=no|t=yes|r=no|m=yes|c=no	2	PMOD
7	exhibited	exhibit	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
8	strong	strong	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	11	NMOD
9	and	and	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	8	COORD
10	consistent	consistent	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	9	CONJ
11	evidence	evidence	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	7	OBJ
12	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	11	NMOD
13	association	association	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	12	PMOD
14	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
15	breast	breast	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	16	NMOD
16	cancer	cancer	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	14	PMOD
17	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	20	P
18	P	p	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
19	<	<	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
20	10	10	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	16	PRN
21	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	22	P
22	-7	-7	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	20	PRN
23	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	22	P
24	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	20	P
25	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	7	P

1	Four	4	Z	Z	rep=no|t=no|r=no|m=yes|c=no	0	root
2	of	of	IN	IN	rep=no|t=no|r=no|m=yes|c=no	1	NMOD
3	these	these	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	4	SBJ
4	contain	contain	VB	VB	rep=no|t=no|r=yes|m=yes|c=no	2	PMOD
5	plausible	plausible	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	7	NMOD
6	causative	causative	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	7	NMOD
7	genes	gene	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	4	OBJ
8	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	11	P
9	FGFR2	FGFR2	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	11	NMOD
10	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	11	P
11	TNRC9	TNRC9	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	7	PRN
12	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	11	COORD
13	MAP3K1	MAP3K1	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	12	COORD
14	and	and	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	13	COORD
15	LSP1	LSP1	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	14	CONJ
16	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	11	P
17	.	.	Fp	Fp	rep=no|t=no|r=no|m=yes|c=no	1	P

1	At	at	IN	IN	rep=no|t=no|r=no|m=yes|c=no	8	TMP
2	the	the	DT	DT	rep=no|t=no|r=no|m=yes|c=no	4	NMOD
3	second	2	JJ	JJ	rep=no|t=no|r=no|m=yes|c=no	4	NMOD
4	stage	stage	NN	NN	rep=no|t=no|r=no|m=yes|c=no	1	PMOD
5	,	,	Fc	Fc	rep=no|t=no|r=no|m=yes|c=no	8	P
6	1,792	1792	Z	Z	rep=no|t=yes|r=no|m=yes|c=no	7	NMOD
7	SNPs	snps	NP00V00	NP	rep=no|t=yes|r=no|m=yes|c=no	8	SBJ
8	were	be	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
9	significant	significant	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	8	PRD
10	at	at	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	9	AMOD
11	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	15	NMOD
12	P	p	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	15	NMOD
13	<	<	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	15	NMOD
14	0.05	0.05	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	13	AMOD
15	level	level	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	10	PMOD
16	compared	compare	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	8	ADV
17	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	16	PMOD
18	an	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
19	estimated	estimate	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
20	1,343	1343	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	17	PMOD
21	that	that	WDT	WDT	rep=no|t=no|r=yes|m=yes|c=no	22	SBJ
22	would	would	MD	MD	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
23	be	be	VB	VB	rep=no|t=no|r=yes|m=yes|c=no	22	VC
24	expected	expect	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	23	VC
25	by_chance	by_chance	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	24	OPRD
26	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	8	P
27	indicating	indicate	VBG	VBG	rep=no|t=no|r=yes|m=yes|c=no	8	ADV
28	that	that	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	27	OBJ
29	many	many	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	32	NMOD
30	additional	additional	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	32	NMOD
31	common	common	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	32	NMOD
32	susceptibility	susceptibility	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	34	SBJ
33	alleles	allele	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	32	APPO
34	may	may	MD	MD	rep=no|t=no|r=yes|m=yes|c=no	28	SUB
35	be	be	VB	VB	rep=no|t=no|r=yes|m=yes|c=no	34	VC
36	identifiable	identifiable	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	35	PRD
37	by	by	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	36	AMOD
38	this	this	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	39	NMOD
39	approach	approach	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	37	PMOD
40	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	8	P

1	Introduction	introduction	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	3	NMOD
2	Breast	breast	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	3	NMOD
3	cancer	cancer	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	4	SBJ
4	is	be	VBZ	VBZ	rep=no|t=no|r=yes|m=yes|c=no	0	root
5	about	about	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	6	NMOD
6	twice	twice	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	4	PRD
7	as	as	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	6	NMOD
8	common	common	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	7	PMOD
9	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	6	LOC
10	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	12	NMOD
11	first-degree	1_degree	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	12	NMOD
12	relatives	relative	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	9	PMOD
13	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	12	NMOD
14	women	woman	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	13	PMOD
15	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	14	NMOD
16	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	17	NMOD
17	disease	disease	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	15	PMOD
18	as	as	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	14	NMOD
19	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	18	LOC
20	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	22	NMOD
21	general	general	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	22	NMOD
22	population	population	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	19	PMOD
23	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	14	P
24	consistent	consistent	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	14	APPO
25	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	24	AMOD
26	variation	variation	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	25	PMOD
27	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	26	LOC
28	genetic	genetic	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	29	NMOD
29	susceptibility	susceptibility	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	27	PMOD
30	to	to	TO	TO	rep=no|t=no|r=yes|m=yes|c=no	26	NMOD
31	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	32	NMOD
32	disease1	disease1	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	30	PMOD
33	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	4	P

1	In	in	IN	IN	rep=no|t=no|r=no|m=yes|c=no	17	TMP
2	the	the	DT	DT	rep=no|t=no|r=no|m=yes|c=no	3	NMOD
3	1990s	1990s	Z	Z	rep=no|t=no|r=no|m=yes|c=no	1	PMOD
4	,	,	Fc	Fc	rep=no|t=no|r=no|m=yes|c=no	17	P
5	two	2	Z	Z	rep=no|t=yes|r=no|m=yes|c=no	8	NMOD
6	major	major	JJ	JJ	rep=no|t=yes|r=no|m=yes|c=no	8	NMOD
7	susceptibility	susceptibility	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	8	NMOD
8	genes	gene	NNS	NNS	rep=no|t=yes|r=no|m=yes|c=no	17	SBJ
9	for	for	IN	IN	rep=no|t=yes|r=no|m=yes|c=no	8	NMOD
10	breast	breast	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	11	NMOD
11	cancer	cancer	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	9	PMOD
12	,	,	Fc	Fc	rep=no|t=yes|r=no|m=yes|c=no	11	P
13	BRCA1	BRCA1	Z	Z	rep=no|t=yes|r=no|m=yes|c=no	11	COORD
14	and	and	CC	CC	rep=no|t=yes|r=no|m=yes|c=no	13	COORD
15	BRCA2	BRCA2	Z	Z	rep=no|t=yes|r=no|m=yes|c=no	14	CONJ
16	,	,	Fc	Fc	rep=no|t=yes|r=no|m=yes|c=no	8	P
17	were	be	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
18	identified	identify	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	17	VC
19	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	17	P

1	Inherited	inherit	VBN	VBN	rep=no|t=yes|r=no|m=yes|c=no	2	NMOD
2	mutations	mutation	NNS	NNS	rep=no|t=yes|r=no|m=yes|c=no	6	SBJ
3	in	in	IN	IN	rep=no|t=yes|r=no|m=yes|c=no	2	LOC
4	these	these	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	5	NMOD
5	genes	gene	NNS	NNS	rep=no|t=yes|r=no|m=yes|c=no	3	PMOD
6	lead	lead	VBP	VBP	rep=no|t=no|r=yes|m=yes|c=no	0	root
7	to	to	TO	TO	rep=no|t=no|r=yes|m=yes|c=no	6	ADV
8	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	10	NMOD
9	high	high	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	10	NMOD
10	risk	risk	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	7	PMOD
11	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	10	NMOD
12	breast	breast	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	11	PMOD
13	and	and	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	12	COORD
14	other	other	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	15	NMOD
15	cancers	cancer	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	13	CONJ
16	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	6	P

1	However	however	RB	RB	rep=no|t=no|r=no|m=yes|c=no	11	ADV
2	,	,	Fc	Fc	rep=no|t=no|r=no|m=yes|c=no	11	P
3	the	the	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	4	NMOD
4	majority	majority	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	11	SBJ
5	of	of	IN	IN	rep=no|t=yes|r=no|m=yes|c=no	4	NMOD
6	multiple	multiple	JJ	JJ	rep=no|t=yes|r=no|m=yes|c=no	10	NMOD
7	case	case	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	9	NMOD
8	breast	breast	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	9	NMOD
9	cancer	cancer	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	10	NMOD
10	families	family	NNS	NNS	rep=no|t=yes|r=no|m=yes|c=no	5	PMOD
11	do	do	VBP	VBP	rep=no|t=no|r=yes|m=yes|c=no	0	root
12	not	not	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	11	ADV
13	segregate	segregate	VB	VB	rep=no|t=no|r=yes|m=yes|c=no	11	VC
14	mutations	mutation	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	13	OBJ
15	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	14	LOC
16	these	these	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	17	NMOD
17	genes	gene	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	15	PMOD
18	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	11	P

1	Subsequent	subsequent	JJ	JJ	rep=no|t=yes|r=no|m=yes|c=no	4	NMOD
2	genetic	genetic	JJ	JJ	rep=no|t=yes|r=no|m=yes|c=no	3	NMOD
3	linkage	linkage	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	4	NMOD
4	studies	study	NNS	NNS	rep=no|t=yes|r=no|m=yes|c=no	5	SBJ
5	have	have	VBP	VBP	rep=no|t=no|r=yes|m=yes|c=no	0	root
6	failed	fail	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	5	VC
7	to	to	TO	TO	rep=no|t=no|r=yes|m=yes|c=no	6	OPRD
8	identify	identify	VB	VB	rep=no|t=no|r=yes|m=yes|c=no	7	IM
9	further	further	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
10	major	major	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
11	breast	breast	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	12	NMOD
12	cancer	cancer	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
13	genes	gene	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	8	OBJ
14	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	5	P

1	These	these	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	2	NMOD
2	observations	observation	NNS	NNS	rep=no|t=yes|r=no|m=yes|c=no	3	SBJ
3	have	have	VBP	VBP	rep=no|t=no|r=yes|m=yes|c=no	0	root
4	led	lead	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	3	VC
5	to	to	TO	TO	rep=no|t=no|r=yes|m=yes|c=no	4	ADV
6	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	7	NMOD
7	proposal	proposal	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	5	PMOD
8	that	that	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	7	NMOD
9	breast	breast	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	10	NMOD
10	cancer	cancer	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	11	NMOD
11	susceptibility	susceptibility	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	12	SBJ
12	is	be	VBZ	VBZ	rep=no|t=no|r=yes|m=yes|c=no	8	SUB
13	largely	largely	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	12	PRD
14	‘	‘	Fra	Fra	rep=no|t=no|r=yes|m=yes|c=no	13	DEP
15	polygenic	polygenic	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	13	AMOD
16	’	’	Frc	Frc	rep=no|t=no|r=yes|m=yes|c=no	13	AMOD
17	:	:	Fd	Fd	rep=no|t=no|r=yes|m=yes|c=no	19	P
18	that	that	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	19	SBJ
19	is	be	VBZ	VBZ	rep=no|t=no|r=yes|m=yes|c=no	7	PRN
20	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	19	P
21	susceptibility	susceptibility	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	22	SBJ
22	is	be	VBZ	VBZ	rep=no|t=no|r=yes|m=yes|c=no	12	EXTR
23	conferred	confer	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	22	VC
24	by	by	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	23	LGS
25	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	27	NMOD
26	large	large	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	27	NMOD
27	number	number	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	24	PMOD
28	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	27	NMOD
29	loci	locus	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	28	PMOD
30	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	27	P
31	each	each	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	27	NMOD
32	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	31	NMOD
33	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	35	NMOD
34	small	small	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	35	NMOD
35	effect	effect	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	32	PMOD
36	on	on	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	35	NMOD
37	breast	breast	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	38	NMOD
38	cancer	cancer	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	39	NMOD
39	risk	risk	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	36	PMOD
40	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	3	P

1	This	this	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	2	NMOD
2	model	model	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	3	SBJ
3	is	be	VBZ	VBZ	rep=no|t=no|r=yes|m=yes|c=no	0	root
4	consistent	consistent	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	3	PRD
5	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	4	AMOD
6	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	8	NMOD
7	observed	observe	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	8	NMOD
8	patterns	pattern	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	5	PMOD
9	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	8	NMOD
10	familial	familial	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	11	NMOD
11	aggregation	aggregation	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	9	PMOD
12	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	11	NMOD
13	breast	breast	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	14	NMOD
14	cancer	cancer	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	12	PMOD
15	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	3	P

1	However	however	RB	RB	rep=no|t=no|r=no|m=yes|c=no	9	ADV
2	,	,	Fc	Fc	rep=no|t=no|r=no|m=yes|c=no	9	P
3	progress	progress	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	9	SBJ
4	in	in	IN	IN	rep=no|t=yes|r=no|m=yes|c=no	3	NMOD
5	identifying	identify	VBG	VBG	rep=no|t=yes|r=no|m=yes|c=no	4	PMOD
6	the	the	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	8	NMOD
7	relevant	relevant	JJ	JJ	rep=no|t=yes|r=no|m=yes|c=no	8	NMOD
8	loci	locus	NNS	NNS	rep=no|t=yes|r=no|m=yes|c=no	5	OBJ
9	has	have	VBZ	VBZ	rep=no|t=no|r=yes|m=yes|c=no	0	root
10	been	be	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	9	VC
11	slow	slow	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	10	PRD
12	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	9	P

1	As	as	IN	IN	rep=no|t=no|r=no|m=yes|c=no	19	ADV
2	linkage	linkage	NN	NN	rep=no|t=no|r=no|m=yes|c=no	3	NMOD
3	studies	study	NNS	NNS	rep=no|t=no|r=no|m=yes|c=no	4	NMOD
4	lack	lack	NN	NN	rep=no|t=no|r=no|m=yes|c=no	5	NMOD
5	power	power	NN	NN	rep=no|t=no|r=no|m=yes|c=no	1	PMOD
6	to	to	TO	TO	rep=no|t=no|r=no|m=yes|c=no	5	NMOD
7	detect	detect	VB	VB	rep=no|t=no|r=no|m=yes|c=no	6	IM
8	alleles	allele	NNS	NNS	rep=no|t=no|r=no|m=yes|c=no	7	OBJ
9	with	with	IN	IN	rep=no|t=no|r=no|m=yes|c=no	7	ADV
10	moderate	moderate	JJ	JJ	rep=no|t=no|r=no|m=yes|c=no	11	NMOD
11	effects	effect	NNS	NNS	rep=no|t=no|r=no|m=yes|c=no	9	PMOD
12	on	on	IN	IN	rep=no|t=no|r=no|m=yes|c=no	11	NMOD
13	risk	risk	NN	NN	rep=no|t=no|r=no|m=yes|c=no	12	PMOD
14	,	,	Fc	Fc	rep=no|t=no|r=no|m=yes|c=no	19	P
15	large	large	JJ	JJ	rep=no|t=yes|r=no|m=yes|c=no	18	NMOD
16	case-control	case_control	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	17	NMOD
17	association	association	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	18	NMOD
18	studies	study	NNS	NNS	rep=no|t=yes|r=no|m=yes|c=no	19	SBJ
19	are	be	VBP	VBP	rep=no|t=no|r=yes|m=yes|c=no	0	root
20	required	require	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	19	VC
21	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	19	P

1	Such	such	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	2	NMOD
2	studies	study	NNS	NNS	rep=no|t=yes|r=no|m=yes|c=no	3	SBJ
3	have	have	VBP	VBP	rep=no|t=no|r=yes|m=yes|c=no	0	root
4	identified	identify	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	3	VC
5	variants	variant	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	4	OBJ
6	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	5	LOC
7	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	9	NMOD
8	DNA	dna	NP00O00	NP	rep=no|t=no|r=yes|m=yes|c=no	9	NMOD
9	repair	repair	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	10	NMOD
10	genes	gene	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	6	PMOD
11	CHEK2	CHEK2	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	12	NMOD
12	​	​	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	20	SBJ
13	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	12	P
14	ATM	atm	NP00G00	NP	rep=no|t=no|r=yes|m=yes|c=no	15	APPO
15	​	​	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	12	COORD
16	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	15	P
17	BRIP1	BRIP1	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	15	COORD
18	and	and	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	17	COORD
19	PALB2that	PALB2that	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	18	CONJ
20	confer	confer	VBP	VBP	rep=no|t=no|r=yes|m=yes|c=no	5	NMOD
21	an	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	24	NMOD
22	approximately	approximately	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	23	AMOD
23	twofold	twofold	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	24	NMOD
24	risk	risk	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	20	OBJ
25	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	24	NMOD
26	breast	breast	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	27	NMOD
27	cancer	cancer	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	25	PMOD
28	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	3	P
29	but	but	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	3	COORD
30	these	these	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	31	NMOD
31	variants	variant	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	32	SBJ
32	are	be	VBP	VBP	rep=no|t=no|r=yes|m=yes|c=no	29	CONJ
33	rare	rare	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	32	PRD
34	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	32	LOC
35	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	36	NMOD
36	population	population	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	34	PMOD
37	-	-	Fg	Fg	rep=no|t=no|r=yes|m=yes|c=no	32	P
38	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	3	P

1	A	a	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	3	NMOD
2	recent	recent	JJ	JJ	rep=no|t=yes|r=no|m=yes|c=no	3	NMOD
3	study	study	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	4	SBJ
4	has	have	VBZ	VBZ	rep=no|t=no|r=yes|m=yes|c=no	0	root
5	shown	show	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	4	VC
6	that	that	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	5	OBJ
7	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	10	NMOD
8	common	common	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	10	NMOD
9	coding	coding	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	10	NMOD
10	variant	variant	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	13	SBJ
11	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	10	NMOD
12	CASP8	CASP8	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	11	PMOD
13	is	be	VBZ	VBZ	rep=no|t=no|r=yes|m=yes|c=no	6	SUB
14	associated	associate	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	13	VC
15	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	14	ADV
16	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	18	NMOD
17	moderate	moderate	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	18	NMOD
18	reduction	reduction	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	15	PMOD
19	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	18	LOC
20	breast	breast	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	21	NMOD
21	cancer	cancer	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	22	NMOD
22	risk	risk	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	19	PMOD
23	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	4	P

1	After	after	IN	IN	rep=no|t=no|r=no|m=yes|c=no	21	TMP
2	accounting	accounting	NN	NN	rep=no|t=no|r=no|m=yes|c=no	1	PMOD
3	for	for	IN	IN	rep=no|t=no|r=no|m=yes|c=no	2	NMOD
4	all	all	DT	DT	rep=no|t=no|r=no|m=yes|c=no	9	NMOD
5	the	the	DT	DT	rep=no|t=no|r=no|m=yes|c=no	9	NMOD
6	known	know	VBN	VBN	rep=no|t=no|r=no|m=yes|c=no	9	NMOD
7	breast	breast	NN	NN	rep=no|t=no|r=no|m=yes|c=no	8	NMOD
8	cancer	cancer	NN	NN	rep=no|t=no|r=no|m=yes|c=no	9	NMOD
9	loci	locus	NNS	NNS	rep=no|t=no|r=no|m=yes|c=no	3	PMOD
10	,	,	Fc	Fc	rep=no|t=no|r=no|m=yes|c=no	21	P
11	more	more	RB	RB	rep=no|t=yes|r=no|m=yes|c=no	13	DEP
12	than	than	IN	IN	rep=no|t=yes|r=no|m=yes|c=no	13	DEP
13	75_%	75/100	Zp	Zp	rep=no|t=yes|r=no|m=yes|c=no	21	SBJ
14	of	of	IN	IN	rep=no|t=yes|r=no|m=yes|c=no	13	NMOD
15	the	the	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	17	NMOD
16	familial	familial	JJ	JJ	rep=no|t=yes|r=no|m=yes|c=no	17	NMOD
17	risk	risk	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	14	PMOD
18	of	of	IN	IN	rep=no|t=yes|r=no|m=yes|c=no	17	NMOD
19	the	the	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	20	NMOD
20	disease	disease	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	18	PMOD
21	remains	remain	VBZ	VBZ	rep=no|t=no|r=yes|m=yes|c=no	0	root
22	unexplained	unexplained	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	21	PRD
23	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	21	P

1	Recent	recent	JJ	JJ	rep=no|t=yes|r=no|m=yes|c=no	3	NMOD
2	technological	technological	JJ	JJ	rep=no|t=yes|r=no|m=yes|c=no	3	NMOD
3	advances	advance	NNS	NNS	rep=no|t=yes|r=no|m=yes|c=no	4	SBJ
4	have	have	VBP	VBP	rep=no|t=no|r=yes|m=yes|c=no	0	root
5	provided	provide	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	4	VC
6	platforms	platform	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	5	OBJ
7	that	that	WDT	WDT	rep=no|t=no|r=yes|m=yes|c=no	8	SBJ
8	allow	allow	VBP	VBP	rep=no|t=no|r=yes|m=yes|c=no	6	NMOD
9	hundreds	hundred	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	8	OBJ
10	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	9	NMOD
11	thousands	thousand	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	10	PMOD
12	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	11	NMOD
13	SNPs	snps	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	12	PMOD
14	to	to	TO	TO	rep=no|t=no|r=yes|m=yes|c=no	8	OPRD
15	be	be	VB	VB	rep=no|t=no|r=yes|m=yes|c=no	14	IM
16	analysed	analyse	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	15	VC
17	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	16	LOC
18	association	association	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	19	NMOD
19	studies	study	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	17	PMOD
20	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	8	P
21	thus	thus	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	22	ADV
22	providing	provide	VBG	VBG	rep=no|t=no|r=yes|m=yes|c=no	8	ADV
23	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	24	NMOD
24	basis	basis	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	22	OBJ
25	for	for	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	24	NMOD
26	identifying	identify	VBG	VBG	rep=no|t=no|r=yes|m=yes|c=no	25	PMOD
27	moderate	moderate	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	28	NMOD
28	risk	risk	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	26	OBJ
29	alleles	allele	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	28	APPO
30	without	without	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	26	ADV
31	prior	prior	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	32	NMOD
32	knowledge	knowledge	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	30	PMOD
33	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	32	NMOD
34	position	position	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	33	PMOD
35	or	or	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	34	COORD
36	function	function	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	35	CONJ
37	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	4	P

1	It	it	PRP	PRP	rep=no|t=yes|r=no|m=yes|c=no	2	SBJ
2	has	have	VBZ	VBZ	rep=no|t=no|r=yes|m=yes|c=no	0	root
3	been	be	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	2	VC
4	estimated	estimate	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	3	VC
5	that	that	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	4	OBJ
6	there	there	EX	EX	rep=no|t=no|r=yes|m=yes|c=no	7	SBJ
7	are	be	VBP	VBP	rep=no|t=no|r=yes|m=yes|c=no	5	SUB
8	7_million	7000000	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	10	NMOD
9	common	common	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	10	NMOD
10	SNPs	snps	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	7	PRD
11	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	10	LOC
12	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	14	NMOD
13	human	human	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	14	NMOD
14	genome	genome	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	11	PMOD
15	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	16	P
16	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	10	PRN
17	minor	minor	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	19	NMOD
18	allele	allele	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	19	NMOD
19	frequency	frequency	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	16	PMOD
20	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	19	P
21	m	m	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	19	COORD
22	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	21	P
23	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	25	NMOD
24	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	23	P
25	f	f	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	21	COORD
26	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	25	P
27	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	25	P
28	>	>	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	29	NMOD
29	5_%	5/100	Zp	Zp	rep=no|t=no|r=yes|m=yes|c=no	25	COORD
30	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	16	P
31	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	2	P

1	However	however	RB	RB	rep=no|t=no|r=no|m=yes|c=no	16	ADV
2	,	,	Fc	Fc	rep=no|t=no|r=no|m=yes|c=no	16	P
3	because	because	IN	IN	rep=no|t=no|r=no|m=yes|c=no	16	PRP
4	recombination	recombination	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	5	SBJ
5	tends	tend	VBZ	VBZ	rep=no|t=no|r=yes|m=yes|c=no	3	SUB
6	to	to	TO	TO	rep=no|t=no|r=yes|m=yes|c=no	5	OPRD
7	occur	occur	VB	VB	rep=no|t=no|r=yes|m=yes|c=no	6	IM
8	at	at	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	7	ADV
9	distinct	distinct	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	12	NMOD
10	‘	‘	Fra	Fra	rep=no|t=no|r=yes|m=yes|c=no	12	NMOD
11	hot-spots	hot-spot	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	12	NMOD
12	’	’	Frc	Frc	rep=no|t=no|r=yes|m=yes|c=no	8	PMOD
13	,	,	Fc	Fc	rep=no|t=no|r=no|m=yes|c=no	16	P
14	neighbouring	neighbour	VBG	VBG	rep=no|t=yes|r=no|m=yes|c=no	15	NMOD
15	polymorphisms	polymorphism	NNS	NNS	rep=no|t=yes|r=no|m=yes|c=no	16	SBJ
16	are	be	VBP	VBP	rep=no|t=no|r=yes|m=yes|c=no	0	root
17	often	often	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	16	TMP
18	strongly	strongly	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	19	MNR
19	correlated	correlate	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	16	VC
20	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	21	P
21	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	19	PRN
22	‘	‘	Fra	Fra	rep=no|t=no|r=yes|m=yes|c=no	23	NMOD
23	linkage	linkage	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	25	NMOD
24	disequilibrium	disequilibrium	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	25	NMOD
25	’	’	Frc	Frc	rep=no|t=no|r=yes|m=yes|c=no	21	PMOD
26	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	25	P
27	LD	ld	NP00G00	NP	rep=no|t=no|r=yes|m=yes|c=no	25	APPO
28	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	25	P
29	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	21	AMOD
30	each	each	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	31	NMOD
31	other	other	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	29	PMOD
32	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	16	P

1	The	the	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	2	NMOD
2	majority	majority	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	7	SBJ
3	of	of	IN	IN	rep=no|t=yes|r=no|m=yes|c=no	2	NMOD
4	common	common	JJ	JJ	rep=no|t=yes|r=no|m=yes|c=no	6	NMOD
5	genetic	genetic	JJ	JJ	rep=no|t=yes|r=no|m=yes|c=no	6	NMOD
6	variants	variant	NNS	NNS	rep=no|t=yes|r=no|m=yes|c=no	3	PMOD
7	can	can	MD	MD	rep=no|t=no|r=yes|m=yes|c=no	0	root
8	therefore	therefore	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	7	ADV
9	be	be	VB	VB	rep=no|t=no|r=yes|m=yes|c=no	7	VC
10	evaluated	evaluate	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	9	VC
11	for	for	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	10	ADV
12	association	association	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	11	PMOD
13	using	use	VBG	VBG	rep=no|t=no|r=yes|m=yes|c=no	12	APPO
14	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	18	NMOD
15	few	few	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	18	NMOD
16	hundred	hundred	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	17	NMOD
17	thousand	thousand	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	18	NMOD
18	SNPs	snps	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	13	OBJ
19	as	as	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	18	NMOD
20	tags	tag	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	19	PMOD
21	for	for	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	13	ADV
22	all	all	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	25	NMOD
23	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	25	NMOD
24	other	other	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	25	NMOD
25	variants	variant	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	21	PMOD
26	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	7	P

1	We	we	PRP	PRP	rep=no|t=no|r=no|m=yes|c=no	0	root
2	aimed	aim	VBN	VBN	rep=no|t=no|r=no|m=yes|c=no	1	APPO
3	to	to	TO	TO	rep=no|t=no|r=no|m=yes|c=no	2	OPRD
4	identify	identify	VB	VB	rep=no|t=no|r=no|m=yes|c=no	3	IM
5	further	further	JJ	JJ	rep=no|t=no|r=no|m=yes|c=no	9	NMOD
6	breast	breast	NN	NN	rep=no|t=no|r=no|m=yes|c=no	7	NMOD
7	cancer	cancer	NN	NN	rep=no|t=no|r=no|m=yes|c=no	8	NMOD
8	susceptibility	susceptibility	NN	NN	rep=no|t=no|r=no|m=yes|c=no	9	NMOD
9	loci	locus	NNS	NNS	rep=no|t=no|r=no|m=yes|c=no	4	OBJ
10	in	in	IN	IN	rep=no|t=no|r=no|m=yes|c=no	4	LOC
11	a	a	DT	DT	rep=no|t=no|r=no|m=yes|c=no	14	NMOD
12	three-stage	three-stage	NN	NN	rep=no|t=no|r=no|m=yes|c=no	13	NMOD
13	association	association	NN	NN	rep=no|t=no|r=no|m=yes|c=no	14	NMOD
14	study	study	NN	NN	rep=no|t=no|r=no|m=yes|c=no	10	PMOD
15	.	.	Fp	Fp	rep=no|t=no|r=no|m=yes|c=no	1	P

1	In	in	IN	IN	rep=no|t=no|r=no|m=yes|c=no	7	TMP
2	the	the	DT	DT	rep=no|t=no|r=no|m=yes|c=no	4	NMOD
3	first	1	JJ	JJ	rep=no|t=no|r=no|m=yes|c=no	4	NMOD
4	stage	stage	NN	NN	rep=no|t=no|r=no|m=yes|c=no	1	PMOD
5	,	,	Fc	Fc	rep=no|t=no|r=no|m=yes|c=no	7	P
6	we	we	PRP	PRP	rep=no|t=yes|r=no|m=yes|c=no	7	SBJ
7	used	use	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
8	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	9	NMOD
9	panel	panel	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	7	OBJ
10	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	9	NMOD
11	266,722	266722	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	12	NMOD
12	SNPs	snps	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	10	PMOD
13	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	12	P
14	selected	select	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	12	APPO
15	to	to	TO	TO	rep=no|t=no|r=yes|m=yes|c=no	14	OPRD
16	tag	tag	VB	VB	rep=no|t=no|r=yes|m=yes|c=no	15	IM
17	known	know	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	19	NMOD
18	common	common	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	19	NMOD
19	variants	variant	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	16	OBJ
20	across	across	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	16	LOC
21	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	23	NMOD
22	entire	entire	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	23	NMOD
23	genome18	genome18	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	20	PMOD
24	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	7	P

1	These	these	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	2	NMOD
2	SNPs	snps	NP00V00	NP	rep=no|t=yes|r=no|m=yes|c=no	3	SBJ
3	were	be	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
4	genotyped	genotype	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	3	VC
5	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	4	LOC
6	408	[??:??/??/408:??.??:??]	W	W	rep=no|t=no|r=yes|m=yes|c=no	9	NMOD
7	breast	breast	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	8	NMOD
8	cancer	cancer	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	9	NMOD
9	cases	case	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	5	PMOD
10	and	and	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	9	COORD
11	400	400	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	12	NMOD
12	controls	control	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	10	CONJ
13	from	from	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	4	ADV
14	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	15	NMOD
15	UK	uk	NP00O00	NP	rep=no|t=no|r=yes|m=yes|c=no	13	PMOD
16	;	;	Fx	Fx	rep=no|t=no|r=yes|m=yes|c=no	3	P
17	data	data	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	18	SBJ
18	were	be	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	3	COORD
19	analysed	analyse	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	18	VC
20	for	for	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	19	ADV
21	390	390	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	22	NMOD
22	cases	case	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	20	PMOD
23	and	and	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	22	COORD
24	364	364	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	25	NMOD
25	controls	control	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	23	CONJ
26	genotyped	genotype	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	22	APPO
27	for	for	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	26	ADV
28	≥	≥	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	29	NMOD
29	80_%	80/100	Zp	Zp	rep=no|t=no|r=yes|m=yes|c=no	27	PMOD
30	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	29	NMOD
31	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	32	NMOD
32	SNPs	snps	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	30	PMOD
33	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	3	P

1	The	the	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	2	NMOD
2	cases	case	NNS	NNS	rep=no|t=yes|r=no|m=yes|c=no	3	SBJ
3	were	be	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
4	selected	select	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	3	VC
5	to	to	TO	TO	rep=no|t=no|r=yes|m=yes|c=no	4	OPRD
6	have	have	VB	VB	rep=no|t=no|r=yes|m=yes|c=no	5	IM
7	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	10	NMOD
8	strong	strong	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	10	NMOD
9	family	family	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	10	NMOD
10	history	history	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	6	OBJ
11	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	10	NMOD
12	breast	breast	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
13	cancer	cancer	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	11	PMOD
14	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	13	P
15	equivalent	equivalent	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	13	APPO
16	to	to	TO	TO	rep=no|t=no|r=yes|m=yes|c=no	15	AMOD
17	at_least	at_least	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	18	NMOD
18	two	2	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	16	PMOD
19	affected	affect	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	18	APPO
20	female	female	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	22	NMOD
21	first-degree	1_degree	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	22	NMOD
22	relatives	relative	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	19	OPRD
23	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	4	P
24	because	because	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	4	PRP
25	such	such	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	26	NMOD
26	cases	case	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	27	SBJ
27	are	be	VBP	VBP	rep=no|t=no|r=yes|m=yes|c=no	24	SUB
28	more	more	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	29	AMOD
29	likely	likely	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	27	PRD
30	to	to	TO	TO	rep=no|t=no|r=yes|m=yes|c=no	29	AMOD
31	carry	carry	VB	VB	rep=no|t=no|r=yes|m=yes|c=no	30	IM
32	susceptibility	susceptibility	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	31	OBJ
33	alleles	allele	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	32	APPO
34	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	3	P

1	Initally	initally	NP00SP0	NP	rep=no|t=no|r=no|m=yes|c=no	0	root
2	,	,	Fc	Fc	rep=no|t=no|r=no|m=yes|c=no	1	P
3	we	we	PRP	PRP	rep=no|t=yes|r=no|m=yes|c=no	4	SBJ
4	analysed	analyse	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	1	COORD
5	227,876	227876	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	6	NMOD
6	SNPs	snps	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	4	OBJ
7	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	8	P
8	85_%	85/100	Zp	Zp	rep=no|t=no|r=yes|m=yes|c=no	6	PRN
9	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	8	P
10	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	6	NMOD
11	genotypes	genotype	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	10	PMOD
12	on	on	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	6	NMOD
13	at_least	at_least	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	14	NMOD
14	80_%	80/100	Zp	Zp	rep=no|t=no|r=yes|m=yes|c=no	12	PMOD
15	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	14	NMOD
16	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	17	NMOD
17	subjects	subject	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	15	PMOD
18	.	.	Fp	Fp	rep=no|t=no|r=no|m=yes|c=no	1	P

1	We	we	PRP	PRP	rep=yes|t=no|r=no|m=no|c=no	2	SBJ
2	estimate	estimate	VBP	VBP	rep=no|t=no|r=no|m=no|c=no	0	root
3	that	that	IN	IN	rep=no|t=no|r=no|m=no|c=no	2	OBJ
4	these	these	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	5	NMOD
5	SNPs	snps	NP00V00	NP	rep=no|t=yes|r=no|m=yes|c=no	6	SBJ
6	are	be	VBP	VBP	rep=no|t=no|r=yes|m=yes|c=no	3	SUB
7	correlated	correlate	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	6	VC
8	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	7	ADV
9	58_%	58/100	Zp	Zp	rep=no|t=no|r=yes|m=yes|c=no	8	PMOD
10	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	9	NMOD
11	common	common	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	12	NMOD
12	SNPs	snps	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	10	PMOD
13	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	9	LOC
14	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
15	HapMap_CEPH	hapmap_ceph	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
16	/	/	Fh	Fh	rep=no|t=no|r=yes|m=yes|c=no	15	COORD
17	CEU	ceu	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	16	CONJ
18	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	20	P
19	Utah	utah	NP00G00	NP	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
20	residents	resident	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	13	PMOD
21	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
22	ancestry	ancestry	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	21	PMOD
23	from	from	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	22	NMOD
24	northern	northern	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	29	NMOD
25	and	and	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	24	COORD
26	western	western	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	25	CONJ
27	Europe	europe	NP00G00	NP	rep=no|t=no|r=yes|m=yes|c=no	24	PMOD
28	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	24	P
29	samples	sample	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	23	PMOD
30	at	at	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	9	LOC
31	r2	r2	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	32	NMOD
32	>	>	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	30	PMOD
33	0.8	0.8	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	32	APPO
34	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	6	P
35	and	and	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	6	COORD
36	77_%	77/100	Zp	Zp	rep=no|t=no|r=yes|m=yes|c=no	35	EXT-GAP
37	at	at	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	42	ADV
38	r2	r2	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	40	NMOD
39	>	>	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	40	NMOD
40	0.5	0.5	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	37	PMOD
41	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	42	P
42	mean	mean	VB	VB	rep=no|t=no|r=yes|m=yes|c=no	35	CONJ
43	r2=0.75	r2=0.75	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	42	OBJ
44	;	;	Fx	Fx	rep=no|t=no|r=yes|m=yes|c=no	42	P
45	see	see	VB	VB	rep=no|t=no|r=yes|m=yes|c=no	42	COORD
46	Supplementary_Fig	supplementary_fig	NP00O00	NP	rep=no|t=no|r=yes|m=yes|c=no	48	NMOD
47	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	48	P
48	1	1	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	45	OBJ
49	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	48	P
50	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	51	P
51	http://www.hapmap.org/	http://www.hapmap.org/	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	48	PRN
52	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	51	P
53	.	.	Fp	Fp	rep=no|t=no|r=no|m=no|c=no	2	P

1	As	as	IN	IN	rep=no|t=no|r=no|m=yes|c=no	5	ADV
2	expected	expect	VBN	VBN	rep=no|t=no|r=no|m=yes|c=no	1	SUB
3	,	,	Fc	Fc	rep=no|t=no|r=no|m=yes|c=no	5	P
4	coverage	coverage	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	5	SBJ
5	was	be	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
6	strongly	strongly	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	7	AMOD
7	related	relate	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	5	PRD
8	to	to	TO	TO	rep=no|t=no|r=yes|m=yes|c=no	7	AMOD
9	m	m	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	8	PMOD
10	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	9	P
11	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	16	NMOD
12	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	13	P
13	f	f	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	16	NMOD
14	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	13	P
15	:	:	Fd	Fd	rep=no|t=no|r=yes|m=yes|c=no	13	P
16	70_%	70/100	Zp	Zp	rep=no|t=no|r=yes|m=yes|c=no	9	APPO
17	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	16	NMOD
18	SNPs	snps	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	17	PMOD
19	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	18	NMOD
20	m	m	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	19	PMOD
21	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	20	P
22	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	24	NMOD
23	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	22	P
24	f	f	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	29	TMP
25	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	20	P
26	>	>	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	27	NMOD
27	10_%	10/100	Zp	Zp	rep=no|t=no|r=yes|m=yes|c=no	28	SBJ
28	were	be	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
29	tagged	tag	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	28	VC
30	at	at	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	29	ADV
31	r2	r2	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	32	NMOD
32	>	>	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	30	PMOD
33	0.8	0.8	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	29	OPRD
34	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	33	P
35	compared	compare	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	33	NMOD
36	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	35	PMOD
37	23_%	23/100	Zp	Zp	rep=no|t=no|r=yes|m=yes|c=no	47	NMOD
38	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	37	NMOD
39	SNPs	snps	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	38	PMOD
40	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	37	NMOD
41	m	m	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	40	PMOD
42	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	37	P
43	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	47	NMOD
44	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	47	P
45	f	f	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	47	DEP
46	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	47	P
47	5	5	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	36	PMOD
48	–	–	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	47	APPO
49	10_%	10/100	Zp	Zp	rep=no|t=no|r=yes|m=yes|c=no	48	EXT
50	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	5	P

1	The	the	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	3	NMOD
2	main	main	JJ	JJ	rep=no|t=yes|r=no|m=yes|c=no	3	NMOD
3	analyses	analysis	NNS	NNS	rep=no|t=yes|r=no|m=yes|c=no	4	SBJ
4	were	be	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
5	restricted	restrict	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	4	VC
6	to	to	TO	TO	rep=no|t=no|r=yes|m=yes|c=no	5	ADV
7	205,586	205586	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	8	NMOD
8	SNPs	snps	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	6	PMOD
9	that	that	WDT	WDT	rep=no|t=no|r=yes|m=yes|c=no	10	SBJ
10	had	have	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	8	NMOD
11	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
12	call	call	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
13	rate	rate	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	10	OBJ
14	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
15	90_%	90/100	Zp	Zp	rep=no|t=no|r=yes|m=yes|c=no	14	PMOD
16	and	and	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	10	COORD
17	whose	whose	WP$	WP$	rep=no|t=no|r=yes|m=yes|c=no	19	NMOD
18	genotype	genotype	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	19	NMOD
19	distributions	distribution	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	20	SBJ
20	did	do	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	16	CONJ
21	not	not	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	20	ADV
22	differ	differ	VB	VB	rep=no|t=no|r=yes|m=yes|c=no	20	VC
23	from	from	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	22	ADV
24	Hardy	hardy	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	23	PMOD
25	–	–	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	24	APPO
26	Weinberg	weinberg	NP00G00	NP	rep=no|t=no|r=yes|m=yes|c=no	27	NMOD
27	equilibrium	equilibrium	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	25	OBJ
28	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	27	NMOD
29	controls	control	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	28	PMOD
30	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	31	P
31	at	at	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	27	PRN
32	P	p	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	34	DEP
33	<	<	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	34	DEP
34	10	10	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	35	NMOD
35	−	−	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	31	PMOD
36	5	5	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	35	NMOD
37	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	31	P
38	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	4	P

1	For	for	IN	IN	rep=no|t=no|r=no|m=yes|c=no	6	TMP
2	the	the	DT	DT	rep=no|t=no|r=no|m=yes|c=no	4	NMOD
3	second	2	JJ	JJ	rep=no|t=no|r=no|m=yes|c=no	4	NMOD
4	stage	stage	NN	NN	rep=no|t=no|r=no|m=yes|c=no	1	PMOD
5	we	we	PRP	PRP	rep=no|t=yes|r=no|m=yes|c=no	6	SBJ
6	selected	select	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
7	12,711	12711	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	8	NMOD
8	SNPs	snps	NP00SP0	NP	rep=no|t=no|r=yes|m=yes|c=no	6	OBJ
9	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	8	P
10	approximately	approximately	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	11	NMOD
11	5_%	5/100	Zp	Zp	rep=no|t=no|r=yes|m=yes|c=no	8	APPO
12	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	11	NMOD
13	those	those	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	12	PMOD
14	typed	type	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	13	APPO
15	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	14	LOC
16	stage	stage	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	17	NMOD
17	1	1	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	15	PMOD
18	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	8	P
19	on	on	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	6	ADV
20	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	21	NMOD
21	basis	basis	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	19	PMOD
22	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	21	NMOD
23	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	24	NMOD
24	significance	significance	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	22	PMOD
25	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	24	NMOD
26	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	27	NMOD
27	difference	difference	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	25	PMOD
28	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	27	NMOD
29	genotype	genotype	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	30	NMOD
30	frequency	frequency	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	28	PMOD
31	between	between	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	27	NMOD
32	cases	case	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	31	PMOD
33	and	and	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	32	COORD
34	controls	control	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	33	CONJ
35	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	6	P

1	These	these	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	2	NMOD
2	SNPs	snps	NP00V00	NP	rep=no|t=yes|r=no|m=yes|c=no	3	SBJ
3	were	be	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
4	then	then	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	3	TMP
5	genotyped	genotype	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	3	VC
6	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	5	LOC
7	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
8	further	further	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
9	3,990	3990	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
10	invasive	invasive	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
11	breast	breast	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	12	NMOD
12	cancer	cancer	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
13	cases	case	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	6	PMOD
14	and	and	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	13	COORD
15	3,916	3916	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	16	NMOD
16	controls	control	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	14	CONJ
17	from	from	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
18	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
19	SEARCH	search	NP00O00	NP	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
20	study	study	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	17	PMOD
21	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	5	P
22	using	use	VBG	VBG	rep=no|t=no|r=yes|m=yes|c=no	5	ADV
23	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	26	NMOD
24	custom-designed	custom_design	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	26	NMOD
25	oligonucleotide	oligonucleotide	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	26	NMOD
26	array	array	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	22	OBJ
27	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	3	P

1	In	in	IN	IN	rep=no|t=no|r=no|m=yes|c=no	7	LOC
2	the	the	DT	DT	rep=no|t=no|r=no|m=yes|c=no	4	NMOD
3	main	main	JJ	JJ	rep=no|t=no|r=no|m=yes|c=no	4	NMOD
4	analyses	analysis	NNS	NNS	rep=no|t=no|r=no|m=yes|c=no	1	PMOD
5	,	,	Fc	Fc	rep=no|t=no|r=no|m=yes|c=no	7	P
6	we	we	PRP	PRP	rep=no|t=yes|r=no|m=yes|c=no	7	SBJ
7	considered	consider	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
8	10,405	10405	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	9	NMOD
9	SNPs	snps	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	7	OBJ
10	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	9	NMOD
11	call	call	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	12	NMOD
12	rate	rate	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	10	PMOD
13	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	12	NMOD
14	>	>	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	15	NMOD
15	95_%	95/100	Zp	Zp	rep=no|t=no|r=yes|m=yes|c=no	13	PMOD
16	that	that	WDT	WDT	rep=no|t=no|r=yes|m=yes|c=no	17	SBJ
17	did	do	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	12	NMOD
18	not	not	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	17	ADV
19	deviate	deviate	VB	VB	rep=no|t=no|r=yes|m=yes|c=no	17	VC
20	from	from	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	19	ADV
21	Hardy	hardy	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	20	PMOD
22	–	–	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	21	APPO
23	Weinberg	weinberg	NP00O00	NP	rep=no|t=no|r=yes|m=yes|c=no	24	NMOD
24	equilibrium	equilibrium	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	22	OBJ
25	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	24	LOC
26	controls	control	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	25	PMOD
27	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	7	P

1	Comparison	comparison	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	11	SBJ
2	of	of	IN	IN	rep=no|t=yes|r=no|m=yes|c=no	1	NMOD
3	the	the	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	7	NMOD
4	observed	observe	VBN	VBN	rep=no|t=yes|r=no|m=yes|c=no	7	NMOD
5	and	and	CC	CC	rep=no|t=yes|r=no|m=yes|c=no	4	COORD
6	expected	expect	VBN	VBN	rep=no|t=yes|r=no|m=yes|c=no	5	CONJ
7	distribution	distribution	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	2	PMOD
8	of	of	IN	IN	rep=no|t=yes|r=no|m=yes|c=no	7	NMOD
9	test	test	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	10	NMOD
10	statistics	statistic	NNS	NNS	rep=no|t=yes|r=no|m=yes|c=no	8	PMOD
11	showed	show	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
12	some	some	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
13	evidence	evidence	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	11	OBJ
14	for	for	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	13	NMOD
15	an	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	16	NMOD
16	inflation	inflation	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	14	PMOD
17	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	16	NMOD
18	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
19	test	test	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
20	statistics	statistic	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	17	PMOD
21	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	20	LOC
22	both	both	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	24	NMOD
23	stage	stage	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	24	NMOD
24	1	1	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	21	PMOD
25	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	32	P
26	inflation	inflation	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	27	NMOD
27	factor	factor	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	28	NMOD
28	λ=1.03	λ=1.03	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	32	NMOD
29	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	32	P
30	95_%	95/100	Zp	Zp	rep=no|t=no|r=yes|m=yes|c=no	32	NMOD
31	confidence	confidence	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	32	NMOD
32	interval	interval	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
33	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	34	P
34	CI	ci	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	32	PRN
35	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	34	P
36	1.02	1.02	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	32	DEP
37	–	–	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	32	COORD
38	1.04	1.04	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	37	PRN
39	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	38	P
40	and	and	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	37	COORD
41	stage	stage	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	40	CONJ
42	2	2	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	41	NMOD
43	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	48	P
44	λ=1.06	λ=1.06	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	48	NMOD
45	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	48	P
46	95_%	95/100	Zp	Zp	rep=no|t=no|r=yes|m=yes|c=no	48	NMOD
47	CI	ci	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	48	NMOD
48	1.04	1.04	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	32	PRN
49	–	–	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	48	APPO
50	1.12	1.12	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	49	NMOD
51	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	48	P
52	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	32	P
53	based	base	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	32	NMOD
54	on	on	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	53	PMOD
55	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	59	NMOD
56	90_%	90/100	Zp	Zp	rep=no|t=no|r=yes|m=yes|c=no	59	NMOD
57	least	least	JJS	JJS	rep=no|t=no|r=yes|m=yes|c=no	58	AMOD
58	significant	significant	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	59	NMOD
59	SNPs	snps	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	54	PMOD
60	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	61	P
61	Fig	fig	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	59	PRN
62	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	61	P
63	1	1	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	61	NMOD
64	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	61	P
65	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	11	P

1	Possible	possible	JJ	JJ	rep=no|t=yes|r=no|m=yes|c=no	2	NMOD
2	explanations	explanation	NNS	NNS	rep=no|t=yes|r=no|m=yes|c=no	6	SBJ
3	for	for	IN	IN	rep=no|t=yes|r=no|m=yes|c=no	2	NMOD
4	this	this	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	5	NMOD
5	inflation	inflation	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	3	PMOD
6	include	include	VBP	VBP	rep=no|t=no|r=yes|m=yes|c=no	0	root
7	population	population	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	6	OBJ
8	stratification	stratification	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	7	NMOD
9	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	7	P
10	cryptic	cryptic	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	11	NMOD
11	relatedness	relatedness	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	7	COORD
12	among	among	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	11	NMOD
13	subjects	subject	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	12	PMOD
14	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	11	P
15	and	and	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	11	COORD
16	differential	differential	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	17	NMOD
17	genotype	genotype	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	15	CONJ
18	calling	call	VBG	VBG	rep=no|t=no|r=yes|m=yes|c=no	17	NMOD
19	between	between	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	17	NMOD
20	cases	case	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	19	PMOD
21	and	and	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	20	COORD
22	controls	control	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	21	CONJ
23	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	6	P

1	There	there	EX	EX	rep=no|t=yes|r=no|m=yes|c=no	2	SBJ
2	was	be	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
3	evidence	evidence	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	2	PRD
4	for	for	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	3	NMOD
5	an	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	6	NMOD
6	excess	excess	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	4	PMOD
7	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	6	NMOD
8	low	low	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	11	NMOD
9	call	call	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	10	NMOD
10	rate	rate	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	11	NMOD
11	SNPs	snps	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	7	PMOD
12	among	among	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	11	LOC
13	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	16	NMOD
14	most	most	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	15	AMOD
15	significant	significant	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	16	NMOD
16	SNPs	snps	NP00V00	NP	rep=no|t=no|r=yes|m=yes|c=no	12	PMOD
17	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	20	P
18	P	p	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
19	<	<	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
20	0.01	0.01	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	16	PRN
21	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	20	P
22	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	16	LOC
23	stage	stage	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	24	NMOD
24	1	1	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	22	PMOD
25	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	2	P
26	but	but	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	2	COORD
27	not	not	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	28	PMOD
28	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	32	ADV
29	stage	stage	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	30	NMOD
30	2	2	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	28	PMOD
31	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	32	P
32	suggesting	suggest	VBG	VBG	rep=no|t=no|r=yes|m=yes|c=no	26	CONJ
33	that	that	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	32	OBJ
34	some	some	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	38	SBJ
35	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	34	NMOD
36	this	this	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	37	NMOD
37	effect	effect	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	35	PMOD
38	is	be	VBZ	VBZ	rep=no|t=no|r=yes|m=yes|c=no	33	SUB
39	a	a	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	40	NMOD
40	genotyping	genotyping	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	38	PRD
41	artefact	artefact	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	40	APPO
42	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	43	P
43	Supplementary_Table	supplementary_table	NP00O00	NP	rep=no|t=no|r=yes|m=yes|c=no	40	APPO
44	1	1	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	43	NMOD
45	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	43	P
46	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	2	P

1	However	however	RB	RB	rep=no|t=no|r=no|m=yes|c=no	5	ADV
2	,	,	Fc	Fc	rep=no|t=no|r=no|m=yes|c=no	5	P
3	the	the	DT	DT	rep=no|t=yes|r=no|m=yes|c=no	4	NMOD
4	inflation	inflation	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	5	SBJ
5	was	be	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
6	still	still	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	5	ADV
7	present	present	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	5	PRD
8	among	among	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	5	ADV
9	SNPs	snps	NP00O00	NP	rep=no|t=no|r=yes|m=yes|c=no	8	PMOD
10	with	with	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	7	AMOD
11	call	call	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	12	NMOD
12	rate	rate	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	10	PMOD
13	>	>	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	14	NMOD
14	99_%	99/100	Zp	Zp	rep=no|t=no|r=yes|m=yes|c=no	12	NMOD
15	in	in	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	14	NMOD
16	both	both	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	17	NMOD
17	cases	case	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	15	PMOD
18	and	and	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	17	COORD
19	controls	control	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	18	CONJ
20	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	14	P
21	possibly	possibly	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	22	ADV
22	reflecting	reflect	VBG	VBG	rep=no|t=no|r=yes|m=yes|c=no	14	COORD
23	population	population	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	24	NMOD
24	sub-structure	sub-structure	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	22	OBJ
25	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	5	P

1	We	we	PRP	PRP	rep=no|t=yes|r=no|m=yes|c=no	2	SBJ
2	computed	compute	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
3	1	1	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	4	NMOD
4	degree	degree	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	2	OBJ
5	of	of	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	4	NMOD
6	freedom	freedom	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	5	PMOD
7	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	8	P
8	d	d	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	15	PMOD
9	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	8	GAP-NMOD
10	f	f	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	8	NMOD
11	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	10	P
12	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	10	P
13	association	association	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	14	NMOD
14	tests	test	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	4	NMOD
15	for	for	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	14	NMOD
16	each	each	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	8	NMOD
17	SNP	snp	NP00O00	NP	rep=no|t=no|r=yes|m=yes|c=no	8	NMOD
18	,	,	Fc	Fc	rep=no|t=no|r=yes|m=yes|c=no	17	P
19	combining	combine	VBG	VBG	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
20	stages	stage	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	17	COORD
21	1	1	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	20	NMOD
22	and	and	CC	CC	rep=no|t=no|r=yes|m=yes|c=no	20	COORD
23	2	2	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	22	CONJ
24	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	17	P

1	After	after	IN	IN	rep=no|t=no|r=no|m=yes|c=no	13	TMP
2	adjustment	adjustment	NN	NN	rep=no|t=no|r=no|m=yes|c=no	1	PMOD
3	for	for	IN	IN	rep=no|t=no|r=no|m=yes|c=no	2	NMOD
4	this	this	DT	DT	rep=no|t=no|r=no|m=yes|c=no	5	NMOD
5	inflation	inflation	NN	NN	rep=no|t=no|r=no|m=yes|c=no	3	PMOD
6	by	by	IN	IN	rep=no|t=no|r=no|m=yes|c=no	2	NMOD
7	the	the	DT	DT	rep=no|t=no|r=no|m=yes|c=no	10	NMOD
8	genomic	genomic	JJ	JJ	rep=no|t=no|r=no|m=yes|c=no	9	NMOD
9	control	control	NN	NN	rep=no|t=no|r=no|m=yes|c=no	10	NMOD
10	method	method	NN	NN	rep=no|t=no|r=no|m=yes|c=no	6	PMOD
11	,	,	Fc	Fc	rep=no|t=no|r=no|m=yes|c=no	13	P
12	we	we	PRP	PRP	rep=no|t=yes|r=no|m=yes|c=no	13	SBJ
13	observed	observe	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
14	more	more	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	15	NMOD
15	associations	association	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	13	OBJ
16	than	than	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	15	NMOD
17	would	would	MD	MD	rep=no|t=no|r=yes|m=yes|c=no	16	SUB
18	have	have	VB	VB	rep=no|t=no|r=yes|m=yes|c=no	17	VC
19	been	be	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	18	VC
20	expected	expect	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	19	VC
21	by_chance	by_chance	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	20	OBJ
22	at	at	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	20	ADV
23	P	p	RB	RB	rep=no|t=no|r=yes|m=yes|c=no	25	NMOD
24	<	<	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	25	NMOD
25	0.05	0.05	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	22	PMOD
26	(	(	Fpa	Fpa	rep=no|t=no|r=yes|m=yes|c=no	27	P
27	Table	table	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	25	PRN
28	1	1	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	27	NMOD
29	)	)	Fpt	Fpt	rep=no|t=no|r=yes|m=yes|c=no	27	P
30	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	13	P

1	One	1	Z	Z	rep=no|t=yes|r=no|m=yes|c=no	2	NMOD
2	SNP	snp	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	7	SBJ
3	(	(	Fpa	Fpa	rep=no|t=yes|r=no|m=yes|c=no	5	P
4	dbSNP	dbsnp	NN	NN	rep=no|t=yes|r=no|m=yes|c=no	5	NMOD
5	rs2981582	rs2981582	Z	Z	rep=no|t=yes|r=no|m=yes|c=no	2	PRN
6	)	)	Fpt	Fpt	rep=no|t=yes|r=no|m=yes|c=no	5	P
7	was	be	VBD	VBD	rep=no|t=no|r=yes|m=yes|c=no	0	root
8	significant	significant	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	7	PRD
9	at	at	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	8	AMOD
10	the	the	DT	DT	rep=no|t=no|r=yes|m=yes|c=no	11	NMOD
11	P	p	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	9	PMOD
12	<	<	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	16	NMOD
13	10	10	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	16	NMOD
14	−	−	Fz	Fz	rep=no|t=no|r=yes|m=yes|c=no	15	NMOD
15	7	7	Z	Z	rep=no|t=no|r=yes|m=yes|c=no	16	NMOD
16	level	level	NN	NN	rep=no|t=no|r=yes|m=yes|c=no	9	COORD
17	that	that	WDT	WDT	rep=no|t=no|r=yes|m=yes|c=no	18	SBJ
18	has	have	VBZ	VBZ	rep=no|t=no|r=yes|m=yes|c=no	16	NMOD
19	been	be	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	18	VC
20	proposed	propose	VBN	VBN	rep=no|t=no|r=yes|m=yes|c=no	19	VC
21	as	as	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	20	ADV
22	appropriate	appropriate	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	21	PMOD
23	for	for	IN	IN	rep=no|t=no|r=yes|m=yes|c=no	20	ADV
24	genome-wide	genome_wide	JJ	JJ	rep=no|t=no|r=yes|m=yes|c=no	25	NMOD
25	studies	study	NNS	NNS	rep=no|t=no|r=yes|m=yes|c=no	23	PMOD
26	.	.	Fp	Fp	rep=no|t=no|r=yes|m=yes|c=no	7	P


